Ultragenyx Pharmaceutical | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Kyowa Hakko Kirin JPY 831.42B 19.39B 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Ultragenyx Pharmaceutical Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.